Drug-Resistant Shigella flexneri 2a, California, USA, 2022 Drug-Resistant Shigella flexneri 2a, California, USA, 2022

Find out how whole-genome sequencing helped guide treatment selection in this case of persistent shigellosis that was refractory to initial drug therapy.Emerging Infectious Diseases
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news